Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1994-12-22
1997-04-29
Davenport, Avis M.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
530300, 530324, 530402, 424400, A61K 3800, A61K 3802, C07K 500, C07K 100
Patent
active
056248989
ABSTRACT:
Disclosed is a method for transporting neurologic therapeutic agents to the brain by means of the olfactory neural pathway and a pharmaceutical composition useful in the treatment of brain disorders.
REFERENCES:
patent: 4464368 (1984-08-01), Cox
patent: 4479932 (1984-10-01), Bodor
patent: 4579585 (1986-04-01), Fern o et al.
patent: 4613500 (1986-09-01), Suzuki et al.
patent: 4639437 (1987-01-01), della Valle et al.
patent: 4746508 (1988-05-01), Carey et al.
patent: 4801575 (1989-01-01), Pardridge
patent: 4822594 (1989-04-01), Gibby
patent: 4895452 (1990-01-01), Yiournas et al.
patent: 4902505 (1990-02-01), Pardridge et al.
patent: 4921705 (1990-05-01), Roberts et al.
W.H. Frey, II and T.A. Ala, Progress in Clinical Neuroscience 1:287-303 (1988).
M. Seiler and M.E. Schwab, Brain Res. 300:33-39 (1984).
Gorio, et al., Neuroscience 8:417-429 (1983).
M.T. Shipley, Brain Res. 15:129-142 (1985).
E. Roberts, Neurobiology of Aging 7:561-567 (1986).
(Editors), Neurobiology of Aging 7:599 (1986).
A. Represa, et al., Brain Res. 457:355-359 (1988).
R.L. Doty, Annals of N.Y. Acad. Sci. 561:76-86 (1989).
Y.W. Chien and S. Chang, In CRC Critical Reviews in Therapeutic Drug Carrier Systems 4:67-194 (1987).
M. Tiemeyer, et al., J. Biol. Chem. 264:1671-1681 (1989).
M.R. Kare, et al., Science 163:952-953 (1969).
C. Ryan, In Focus On 7:1-13 (1986) (University of Cincinnati Medical Center).
J. Altman, Nature 337:688 (1989).
M. King, In The Atlanta Journal (Science/Medicine Section) (Apr. 11, 1989).
B.R. Talamo, et al., Nature 337:736-739 (1989).
R.C.A. Pearson, et al., Proc. Nat'l. Acad. Sci. 82:4531-4534 (1985).
C.H. Phelps, et al., Neurobiology of Aging 10:205-207 (1989).
Hardy, et al., "Intranasal Drug Delivery by Spray and Drops", J. Pharm. Pharmacol., 37, 294-97 (1985).
Aoki, et al., "Distribution and Removal of Human Serum Albumin--Technetium 99m Instilled Intranasally", Br. J. Clin. Pharmac., 3, 869-878 (1976).
Ang et al., "Blood-cerebrospinal fluid barrier to arginine vasopressin, desmopressin and desglycinamide arginine-vasopressin in the dog", J. Endocrin., 93, pp. 319-325 (1982).
Boies et al., Fundamentals of Otolaryngology, W.B. Saunders Co., Philadelphia, pp. 184-185 (1989).
Broadwell, "Transcytosis of macromolecules through the blood-brain barrier: a cell biological perspective and critical appraisal", Acta Neuropathol, 79, pp. 117-128 (1989).
Chien et al., Nasal Systemic Drug Delivery, Marcel Dekker, Inc., New York, pp. 18-19, 44-49, 56-59, 82-85, 292-293 (1989).
Eisenbarth et al., "Monoclonal antibody to a plasma membrane antigen of neurons", Proc. Natl. Acad. Sci. USA, 76, pp. 4913-4917 (1979).
Emory et al., "Ganglioside Monoclonal Antibody (A2B5) Neurofibrillary Tangles", Fed. Proceedings, 45, p. 1728 (1986).
Emory et al., "Ganglioside Monoclonal Antibody (A2B5) Neurofibrillary Tangles", Neurology, 37, pp. 768-772 (1987).
Eppstein et al., "Alternative Delivery Systems for Peptides and Proteins as Drugs", CRC Critical Reviews in Therapeutic Drug Carrier Systems, 5, pp. 99-139 (1988).
Fabian et al., "Intraneuronal IgG in the central nervous system: Uptake by retrograde axonal transport", Neurology, 37, pp. 1780-1784 (1987).
Galanos et al., "Preparation and Properties of Antisera against the Lipid-A Component of Bacterial Lipopolysaccharides", Eur. J. Biochem., 24, pp. 116-122 (1971).
Gopinath et al., "Target Site of Intranasally Sprayed Substances and Their Transport Across the Nasal Mucosa: A New Insight Into the Intranasal Route of Drug-Delivery", Current Therapeutic Research, 23, pp. 596-607 (1978).
Graziadei et al., "Neurogenesis and neuron regeneration in the olfactory system of mammals. I. Morphological aspects of differentiation and structural organization of the olfactory sensory neurons", J. Neurocytol., 8, pp. 1-18 (1979).
Hammerschlag et al., "Axonal Transport and the Neuronal Cytoskeleton", Basic Neurochemistry: Molecular, Cellular, and Medical Aspects, G.J. Siegel et al., eds., Raven Press Ltd., New York (4th ed.), pp. 457-478 (1989).
Hefti et al., "Function of Neurotrophic Factors in the Adult and Aging Brain and Their Possible Use in the Treatment of Neuro degenerative Diseases", Neurobiol. Aging, 10, pp. 515-533 (1989).
Kasai et al., "The monoclonal antibody A2B5 is specific to ganglioside G.sub.Q1c ", Brain Research, 277, pp. 155-158 (1983).
Kumar et al., "Pharmacokinetics of progesterone after its administration to ovariectomized rhesus monkeys by injection, infusion, or nasal spraying", Proc. Natl. Acad. Sci. USA, 79, pp. 4185-4189 (1982).
Lee et al., "Intranasal Delivery of Proteins and Peptides", BioPharm, pp. 30-37 (Apr. 1988).
Pitha et al., "Drug Solubizers to Aid Pharmacologists: Amorphous Cyclodextrin Derivatives", Life Sciences, 43, pp. 493-502 (1988).
Rapport et al., "Present Status of the Immunology of Gangliosides", Advances in Experimental Medicine and Biology, R.W. Ledenn et al., eds., 174, pp. 15-25 (1984).
Snyder et al., "Molecular Mechanisms of Olfaction", J. Biol. Chem., 263, pp. 13971-13974 (1988).
Stryer, Biochemistry, W.H. Freeman and Company, New York, pp. 288-291 (1988).
Young et al., "Production of Monoclonal Antibodies Specific for Two Distinct Steric Portions of the Glycolipid Ganglio-N Triosylceramide (Asialo GM.sub.2)", J. Exp. Med., 150, pp. 1008-1019 (1979).
Davenport Avis M.
Ramsey Foundation
LandOfFree
Method for administering neurologic agents to the brain does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for administering neurologic agents to the brain, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for administering neurologic agents to the brain will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-705616